PCSK9 in Vascular Aging and Age-Related Diseases
Aging and disease · 2025
DOI: 10.14336/ad.2024.1713 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Aging and disease, 2025. Verfasst von Dong Tan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, the Second Affiliated Hospital of University of South China, Hengyang, Hunan, China. Hauptthemen laut MEDLINE: Proprotein Convertase 9, Aging, Cardiovascular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 203 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The aging process significantly contributes to human disease, and as worldwide life expectancy increases, addressing the challenges of aging and age-related cardiovascular diseases is becoming increasingly urgent. Vascular aging is a key link between aging and the development of age-related diseases. Recent studies indicate that proprotein convertase subtilisin/kexin type 9 (PCSK9), a type of protein involved in the metabolism of lipids, is crucial in modulating vascular aging by affecting the physiological functioning of vascular cells. PCSK9 is linked to lipid metabolism and chronic inflammation and is involved in regulating senescence-related activities, including migration, proliferation, apoptosis, and differentiation. These factors contribute to the aging of vascular cells and age-related vascular diseases, including atherosclerosis, hypertension, coronary artery disease, and cerebrovascular diseases. Given its involvement in these processes, this article provides a comprehensive summary of PCSK9's regulatory functions in vascular aging, highlighting potential therapeutic targets for combating age-related cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Vascular Surgery, the Second Affiliated Hospital of University of South China, Hengyang, Hunan, China.
- Pan-Vascular Research Group, Shenzhen University Affiliated Sixth Hospital, Shenzhen, Guangdong, China.
- Department of Metabolism and Endocrinology, the First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
- Department of Urology, Shenzhen University Affiliated Sixth Hospital, Shenzhen, Guangdong Province, China.
- Hunan Province Thrombotic Disease Prevention and Treatment Clinical Medical Research Center, The Third Affiliated Hospital of University of South China, Hengyang, Hunan, China.
- Hunan Province Thrombotic Disease Prevention and Treatment Clinical Medical Research Center, The Second Affiliated Hospital of University of South China, Hengyang, Hunan, China.
Zitieren
APA
Tan, D., Yang, X., Yang, J., Fan, G., & Xiong, G. (2025). PCSK9 in Vascular Aging and Age-Related Diseases. Aging and disease. https://doi.org/10.14336/ad.2024.1713
Vancouver
Tan D, Yang X, Yang J, Fan G, Xiong G. PCSK9 in Vascular Aging and Age-Related Diseases. Aging and disease. 2025. doi:10.14336/ad.2024.1713
BibTeX
@article{Tan2025,
author = {Tan, Dong and Yang, Xin and Yang, Jing and Fan, Gang and Xiong, Guozuo},
title = {PCSK9 in Vascular Aging and Age-Related Diseases},
journal = {Aging and disease},
year = {2025},
doi = {10.14336/ad.2024.1713}
}
EUVIMED